Reuters - Pharmaceutical group Novartis said on
Monday it had received U.S. approval for Exelon Patch, which
delivers a treatment for Alzheimer's disease through a skin
patch instead of an oral capsule.
Source: http://rss.news.yahoo.com
Monday, July 9, 2007
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment